Hair Regrowth in Alopecia Areata Patients: Insights from a Case Study Using Mesenchymal Stem Cell Conditioned Media
October 2024
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This case report describes a patient with alopecia areata who showed visible hair growth after two months of topical treatment with MSC-derived Conditioned Media, suggesting potential benefits for hair regrowth. Our plain-language summary of this paper — not a Tressless recommendation.
This case study explores the use of Mesenchymal Stem Cell-derived Conditioned Media (MSC-CM) for treating a patient with alopecia areata, an autoimmune disorder causing hair loss. The patient underwent a two-month topical treatment with MSC-CM, resulting in significant hair regrowth in the vertex scalp area, as indicated by a reduction in the Severity of Alopecia Tool (SALT) score from 6% to nearly 0%. The study suggests that MSC-CM, which contains growth factors and cytokines, can effectively promote hair regeneration by influencing hair follicle growth and vascularization.
